Jevtana (Cabazitaxel Vials) 60mg/1.5ml

Jevtana (cabazitaxel) 60mg/1.5ml is a prescription chemotherapy injection used for certain types of cancer treatment. This sterile vial formulation is designed for intravenous administration under medical supervision. Always consult a healthcare provider for proper use and dosing.

Strength

60mg/1.5ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Sanofi Aventis Deutschland Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cabazitaxel is primarily used to treat prostate cancer that has spread and worsened despite other treatments. It belongs to a class of medications called taxanes, which work by slowing or stopping cancer cell growth. Healthcare professionals may also consider cabazitaxel for other off-label oncological uses based on individual patient needs.

Side Effects

As a chemotherapy agent, cabazitaxel may help reduce tumor size and slow disease progression. Patients might experience temporary changes in energy levels or appetite during treatment. Individual responses vary, and effects are typically monitored by a healthcare provider throughout therapy.

Precautions & Warnings

This medication should only be handled and administered by trained medical professionals in a clinical setting. Proper protective measures are essential during preparation and administration to minimize exposure risks. Patients should discuss their full medical history with their doctor before starting cabazitaxel.

Avoid Interactions

Cabazitaxel may interact with other medications, including certain blood thinners, antifungals, or heart medications. Strong CYP3A inhibitors can increase cabazitaxel levels in the body, potentially affecting safety. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using.

References

Frequently Asked Questions

Cabazitaxel is used to treat advanced prostate cancer that has progressed despite other therapies.

Cabazitaxel is given as an intravenous infusion by healthcare professionals in a medical setting.

Common effects may include fatigue, nausea, or changes in blood cell counts, which should be monitored by a doctor.

Cabazitaxel requires a prescription and should only be obtained through licensed medical providers or pharmacies.

Yes, cabazitaxel is a chemotherapy medication used in cancer treatment.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.